Underrepresentation of non-white children in trials of statins in children with heterozygous familial hypercholesterolemia

Ethnicity and Disease

Volumn 19, Issue 2, 2009, Pages 166-171

  Belay, Brook ^a   Racine, Andrew D ^b   Belamarich, Peter F ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cholesterol; Familial hypercholesterolemia; Guidelines; Health services accessibility; HMG CoA reductase inhibitors; Minority groups; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CLINICAL TRIAL; DRUG EFFECT; ETHNICITY; FAMILIAL HYPERCHOLESTEROLEMIA; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DISPARITY; HUMAN; PRACTICE GUIDELINE; CAUCASIAN; CHILD; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; HYPERLIPOPROTEINEMIA TYPE 2; MINORITY GROUP; PATIENT SELECTION; REVIEW; STATISTICS;

CHILD; CLINICAL TRIALS AS TOPIC; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; MINORITY GROUPS; PATIENT SELECTION; SELECTION BIAS;

EID: 67651233715     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Knipscheer HC, Boelen CCA, Kastelein JJP, et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res. 1996;39(5):867-871.
2. McCrindle BW, Ose L, Marais AD. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr. 2003;142(1):74-80. (Pubitemid 36928572)
3. Clauss SB, Holmes KW, Hopkins P, et al. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics. 2005;116(3):682-688. (Pubitemid 44336686)
4. National Institutes of Health. Inclusion of women and minorities as participants in research involving human subjects - policy implementation page. Available at http://grants.nih.gov/grants/funding/women-min/women-min.htm. Accessed 5/15/2008.
5. Healthy People 2010. 2nd ed. Washington, DC: US Government Printing Office; 2000.
6. Corbie-Smith G, Moody-Ayers S, Thrasher AD. Closing the circle between minority inclusion in research and health disparities. Arch Intern Med. 2004;164(13):1362-1364. (Pubitemid 38949796)
7. Clark LT. Issues in minority health, atherosclerosis and coronary heart disease in African Americans. Med Clin North Am. 2005;89(5):977-1001.
8. Mensah GA. Eliminating disparities in cardiovascular health: six strategic imperatives and a framework for action. Circulation. 2005;111(10):1332-1336.
9. Dennison BA, Kikuchi DA, Srinivasan SR, Webber LS, Berenson GS. Parental history of cardiovascular disease as an indication for screening for lipoprotein abnormalities in children. J Pediatr. 1989;115(2):186-194.
10. Wadowski S, Karp RJ, Murray-Buchmann R, Senft C. Family History of coronary artery disease and cholesterol: screening children in a disadvantaged inner-city population. Pediatrics. 1994;93(1):109-113. (Pubitemid 24012139)
11. Rifai N, Neufield E, Ahlstrom P, Rimm E, D'Angelo L, Hicks JM. Failure of current guidelines for cholesterol screening in urban African American adolescents. Pediatrics. 1996;98(3):383-388. (Pubitemid 26295838)
12. Online Mendelian Inheritance in Man. 606945 Low-density lipoprotein receptor. Available at http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi? id5606945. Accessed 5/15/2008.
13. Defesche JC, Kastelein JJ. Molecular epidemiology of familial hypercholesterolemia. Lancet. 1998;352(9141):1643-1644.
14. National Cholesterol Education Program. Report of the Expert Panel on Blood Cholesterol in Children and Adolescents. National Heart Lung and Blood Institute, Public Health Service, US Department of Health and Human Services. NIH Publication No. 91-2732, Bethesda, Md: National Heart Lung and Blood Institute; 1991.
15. United States Census Bureau. Available at http://www.census.gov/ population/www/socdemo/hh-fam/cps2006.html. Accessed 5//19/2008.
16. Couture P, Brun LD, Szots F, et al. Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1998;18(6):1007-1012. (Pubitemid 28272598)
17. Stein EA, Illingworth DR, Kwiterovich PO, et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia. JAMA. 1999;281(2):137-144.
18. de Jongh S, Ose L, Szamosi T, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation. 2002;106(17):2231-2237. (Pubitemid 35222218)
19. de Jongh S, Lilien MR, op't Roodt J, et al. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol. 2002;40(12):2117-2121.
20. Weigman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia. JAMA. 2004;292(3):331-337. (Pubitemid 39369205)
21. Ducobu J, Brasseur D, Chaudron JM, et al. Simvastatin use in children. Lancet. 1992;339(8807):1488.
22. Sinzinger H, Schmid P, Pirich C, et al. Treatment of hypercholesterolemia in children. Lancet. 1992;340(8818):548-549.
23. Athyros VG, Papageorgiou AA, Kontopoulos AG. Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia. Atherosclerosis. 2002;163(1):205-206.
24. Dirisamer A, Hachemian N, Bucek RA, Wolf F, Reiter M, Widhalm K. The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation. Eur J Pediatr. 2003;162(6):421-425. (Pubitemid 36693745)
25. Hedman M, Matikainen T, Fohr A, et al. Efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia: a prospective clinical follow-up study. J Clin Endocrinol Metab. 2005;90(4):1942-1952. (Pubitemid 40586225)
26. van der Graaf A, Nierman MC, Firth JC, Wolmarans KH, Marais D, de Groot E. Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia. Acta Paediatrica. 2006;95(11):1461-1466. (Pubitemid 44643563)
27. Lambert M, Lupien PJ, Cagne C, et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Pediatrics. 1996;97(5):619-628.
28. Stefanutti C, Lucani G, Vivenzio A, Di Giacomo S. Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood. Drugs Exp Clin Res. 1999;24(1):23-28. (Pubitemid 29199589)
29. McCrindle BW, Helden E, Cullen-Dean G, et al. A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia. Pediatr Res. 2002;51(6):715-721. (Pubitemid 34547334)
30. Nelson K, Norris K, Mangione CM. Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity. Arch Intern Med. 2002;162(8):929-935.
31. Stewart SH, Silverstein MD. Racial and ethnic disparity in blood pressure and cholesterol measurement. J Gen Intern Med. 2002;17(6):405-411.
32. Brown DW, Giles WH, Greenlund KJ, Croft JB. Disparities in cholesterol screening: falling short of a national health objective. Prev Med. 2001;33(6):517-522.
33. Resnicow K, Cross D. Are parents' self-reported total cholesterol levels useful in identifying children with hyperlipidemia? An examination of current guidelines. Pediatrics. 1993;92(3):347-353. (Pubitemid 23264629)
34. The World Factbook. Available at https://www.cia.gov/library/ publications/the-world-factbook/geos/nl.html. Accessed 5/20/2008.
35. Starc TJ, Belamarich PF, Shea S, et al. Family history fails to identify many children with severe hypercholesterolemia. Am J Dis Child. 1991;145(1):61-64.
36. O'Laughlin J, Lauzon B, Paradis G, Hanley J, Levy E, Delvin E, Lambert M. Usefulness of the American Academy of Pediatrics recommendations for identifying youths with hypercholesterolemia. Pediatrics. 2004;113(6):1723-1727. (Pubitemid 38697982)
37. Gidding S. Cholesterol guidelines debate. Pediatrics. 2001;107(5):1229-1230.
38. Newman TB, Garber A. Cholesterol screening in children and adolescents. Pediatrics. 2000;105(3 Pt 1):637-638.
39. National Center for Health Statistics Health. Chartbook on Trends in the Health of Americans. Hyattsville, Md: National Center for Health Statistics; 2006.